2021 "Campaign for Cures" to Help Develop an Ethical COVID-19 Vaccine and Novel Therapies
The John Paul II Medical Research Institute (JP2MRI) was established in 2006 with a mission to
find new therapies and cures exclusively using adult stem cells and induced pluripotent stem
The Institute does NOT engage in any embryonic stem cell research and seeks to develop
preclinical research technologies that will advance drug discovery and regenerative medicine in
the following core research areas: 1) Neurodegenerative Diseases; 2) Rare Diseases; 3) Cancer;
and 4) Chronic Diseases.
And, JP2MRI is also currently hoping to develop a more effective and ethical
SARS-CoV-2 vaccine that is free of all aborted fetal tissue and cell use in both development and
The Institute is making progress on our vaccine developmental efforts and has already
raised some of the necessary funding to assist with the significant costs associated with this
However, we need to raise much more financial capital before our vaccine candidates
can be validated.
JP2MRI will need to test our vaccines in an academic BSL3 facility that is
certified to contain infectious pathogens like COVID-19.
These studies are required by the Food
and Drug Administration and are unfortunately very expensive.
JP2MRI needs to raise an
additional $500,000 before the end of the year to help defray the costs of producing a pipeline of
attenuated vaccines; produce new adult stem cell lines for vaccine testing; and conduct
preclinical animal testing to identify the lead vaccine candidate that will be selected for more
rigorous efficacy and safety studies.
It is our hope to develop a more robust, durable and ethical
coronavirus vaccine than those which are currently being administered under the FDA’s
Emergency Use Authorization and which were designed, manufactured and/or tested with
aborted fetal cells.
Please join this important campaign by making a meaningful, tax-deductible
To learn more about our "Campaign for Cures," please visit jp2mri.org